Literature DB >> 8738701

Vitiligo in Vogt-Koyanagi-Harada disease: immunohistological analysis of inflammatory site.

T Okada1, T Sakamoto, T Ishibashi, H Inomata.   

Abstract

BACKGROUND: Vogt-Koyanagi-Harada disease (VKH) consists of uveitis with associated non-ocular symptoms, such as vitiligo or central nervous system disorders. A cell-mediated immune disorder is believed to play an important role in VKH; however, the skin lesion has not been well studied. Therefore, for this study, we examined the skin of a 56-year-old Japanese man with Vogt-Koyanagi-Harada disease (VKH).
METHODS: Skin biopsy specimens from the patient's vitiligo were obtained 1 month after the onset of ocular symptoms. Immunohistochemical analysis of the specimens study was performed using the following monoclonal antibodies: anti-T cell, anti-B cell, anti-major histocompatibility complex class II (HLA-DR), anti-T helper/inducer (CD4), and anti-T suppressor/ cytotoxic lymphocytes (CD8).
RESULTS: Histopathologic analysis revealed mononuclear cell infiltration of the slightly edematous dermis, especially surrounding the hair follicles and sweat glands. Melaninladen cells in the epidermis were partially lost. The infiltrating mononuclear cells consisted primarily of T lymphocytes with a smaller number of B lymphocytes. Most showed expression of HLA-DR. CD4-positive lymphocytes were dominant over CD8-positive cells (3:1).
CONCLUSIONS: The results indicate that vitiligo of VKH is infiltrated by mostly activated helper/inducer lymphocytes and that cell-mediated immunity plays an important role in the pathogenesis of the dermal lesions of VKH as well.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738701     DOI: 10.1007/bf00190711

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  4 in total

1.  Graft rejection and Ia antigens--paradox resolved?

Authors:  A N Barclay; D W Mason
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

2.  Class II major histocompatibility complex on melanocytes of Vogt-Koyanagi-Harada disease.

Authors:  T Sakamoto; T Murata; H Inomata
Journal:  Arch Ophthalmol       Date:  1991-09

3.  Immunopathologic study of Vogt-Koyanagi-Harada syndrome.

Authors:  C C Chan; A G Palestine; T Kuwabara; R B Nussenblatt
Journal:  Am J Ophthalmol       Date:  1988-06-15       Impact factor: 5.258

4.  Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus.

Authors:  H Inomata; T Sakamoto
Journal:  Curr Eye Res       Date:  1990       Impact factor: 2.424

  4 in total
  6 in total

Review 1.  A review of immunologic diseases of the dog.

Authors:  N C Pedersen
Journal:  Vet Immunol Immunopathol       Date:  1999-08-02       Impact factor: 2.046

2.  IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis.

Authors:  Yan Ke; Deming Sun; Guomin Jiang; Henry J Kaplan; Hui Shao
Journal:  J Immunol       Date:  2011-07-27       Impact factor: 5.422

3.  Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.

Authors:  Francesco Caso; Donato Rigante; Antonio Vitale; Luisa Costa; Vittoria Bascherini; Eugenia Latronico; Rossella Franceschini; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2014-09-16       Impact factor: 2.980

4.  Vogt-Koyanagi-Harada patients show higher frequencies of circulating NKG2Dpos NK and NK T cells.

Authors:  M Bonacini; L Cimino; L De Simone; E Bolletta; F Gozzi; A Soriano; F Muratore; A Zerbini; L Fontana; C Salvarani; S Croci
Journal:  Clin Exp Immunol       Date:  2020-12-27       Impact factor: 5.732

5.  Identification of differently expressed mRNAs by peripheral blood mononuclear cells in Vogt-Koyanagi-Harada disease.

Authors:  Yujing Li; Guannan Su; Fanfan Huang; Ying Zhu; Xiang Luo; Aize Kijlstra; Peizeng Yang
Journal:  Genes Dis       Date:  2021-06-30

Review 6.  Vogt-Koyanagi-Harada (VKH) syndrome: A new perspective for healthcare professionals.

Authors:  Yojana B Patil; Ruchira Garg; Jagadish Prasad Rajguru; Manjunath Sirsalmath; Varsha A Bevinakatti; Manish Kumar; Sonika Sharma
Journal:  J Family Med Prim Care       Date:  2020-01-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.